FIELD: pharmacology.
SUBSTANCE: application of calcium bis(2-aminoethane-1-sulfonate) as a means of systemic hemostatic effect is proposed.
EFFECT: application of the invention extends the arsenal of biologically active substances, including those with a systemic hemostatic effect; the compound exhibits an effective hemostatic effect due to proaggregant activity as compared to ethamylate.
2 tbl
Title | Year | Author | Number |
---|---|---|---|
SALTS OF [3-METHYL-1-N-PROPYL-7-(1,1-DIOXOTHIETANYL-3)XANTHINYL-8-THIO]ACETIC ACID, EXHIBITING PROAGGREGANT ACTIVITY | 2011 |
|
RU2459825C1 |
METHOD OF PREVENTION OF BLEEDING CAUSED BY THE APPLICATION OF ANTIAGREGANTS, EXPERIMENT STAGE | 2017 |
|
RU2645630C1 |
METHOD FOR PRODUCTION OF BAKERY PRODUCTS ENRICHED WITH CALCIUM | 2021 |
|
RU2767994C1 |
HAEMOSTATIC COMPOSITION (EMBODIMENTS) | 2022 |
|
RU2826621C2 |
USE OF 5,7-DIHYDROXY-6,8-DIMETHYLFLAVANONE AS ANTI-AGGREGATION ACTIVITY | 2023 |
|
RU2812630C1 |
USE OF 2,3,4-TRIMETHOXY-5-HYDROXY-9,10-DIHYDROPHENANTHRENE AS AN AGENT WITH ANTI-AGGREGATION ACTIVITY | 2023 |
|
RU2808460C1 |
USE OF 4-O-α-ARABINOFURANOSYLAGIC ACID AS ANTI-AGGREGATION ACTIVITY | 2023 |
|
RU2811240C1 |
AGENT EXHIBITING ANTIAGGREGATORY ACTIVITY | 2019 |
|
RU2727508C1 |
N'-PYRIDIN-4-YLMETHYLENE-2-[6-METHYL-4-(THIETAN-3-YLOXY)PYRIMIDIN-2-YLTHIO]ACETOHYDRAZIDE, HAVING ANTIAGGREGATION AND ANTICOAGULANT ACTIVITY | 2024 |
|
RU2825129C1 |
USE OF 1-(3,5-DIHYDROXY-4-METHOXYPHENYL)-2-(3-HYDROXYPHENYL)-ETHANE WITH ANTI-AGGREGATION ACTIVITY | 2023 |
|
RU2806331C1 |
Authors
Dates
2017-12-26—Published
2017-05-10—Filed